Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3083% above fair value
$24.99−0.27 (-1.07%)
Close on Nov 17, 2026Market cap $3.19BP/E 119.0Yield –
Privia Health total assets
Total assets on the balance sheet at the end of each period.
Privia Health's total assets was $1.49B at Jun 30, 2026. For fiscal 2025 it was $1.37B, up 20.6% from the year before. The highest annual figure on record is $1.37B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.37B | +20.6% |
| FY2024 | Dec 31, 2024 | $1.14B | +13.6% |
| FY2023 | Dec 31, 2023 | $999.90M | +26.1% |
| FY2022 | Dec 31, 2022 | $792.81M | +15.5% |
| FY2021 | Dec 31, 2021 | $686.37M | +108.6% |
| FY2020 | Dec 31, 2020 | $328.97M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.49B | +17.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.42B | +19.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.37B | +20.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.35B | +17.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.27B | +18.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.18B | +14.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.14B | +13.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.15B | +15.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.08B | +14.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.03B | +17.8% |
| Q4 FY2023 | Dec 31, 2023 | $999.90M | +26.1% |
| Q3 FY2023 | Sep 30, 2023 | $992.33M | +22.8% |
| Q2 FY2023 | Jun 30, 2023 | $937.57M | +25.9% |
| Q1 FY2023 | Mar 31, 2023 | $875.34M | +21.0% |
| Q4 FY2022 | Dec 31, 2022 | $792.81M | +15.5% |
| Q3 FY2022 | Sep 30, 2022 | $807.79M | +27.8% |
| Q2 FY2022 | Jun 30, 2022 | $744.99M | +24.8% |
| Q1 FY2022 | Mar 31, 2022 | $723.18M | +107.6% |
| Q4 FY2021 | Dec 31, 2021 | $686.37M | +108.6% |
| Q3 FY2021 | Sep 30, 2021 | $632.06M | – |
| Q2 FY2021 | Jun 30, 2021 | $597.14M | – |
| Q1 FY2021 | Mar 31, 2021 | $348.28M | – |
| Q4 FY2020 | Dec 31, 2020 | $328.97M | – |
See a number that looks wrong?